Review
World J Pharmacol
3(4):39-55.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.39
Abstract (2233)
|
Core Tip (2072)
|
Full Article (HTML) (17418)
|
Figures (1-3) (607)
|
Tables (1-5) (600)
|
Full Article (PDF)-1451K (1393)
|
Peer-Review Report-94K (438)
|
Answering Reviewers-72K (370)
|
Received: 06/26/2014
|
Revised: 09/09/2014
|
Accepted: 10/10/2014
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (65)
|
Total Visits (32566)
|
Similar Articles (7)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):56-71.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.56
Abstract (2196)
|
Core Tip (1823)
|
Full Article (HTML) (10124)
|
Figures (1-1) (1070)
|
Tables (1-3) (536)
|
Full Article (PDF)-1210K (831)
|
Peer-Review Report-98K (404)
|
Answering Reviewers-99K (333)
|
Received: 07/01/2014
|
Revised: 08/01/2014
|
Accepted: 09/17/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (21507)
|
Similar Articles (171)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):72-85.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.72
Abstract (1974)
|
Core Tip (1810)
|
Full Article (HTML) (10320)
|
Figures (1-4) (1577)
|
Tables (1-1) (546)
|
Full Article (PDF)-1374K (1183)
|
Peer-Review Report-105K (373)
|
Answering Reviewers-58K (468)
|
Received: 07/28/2014
|
Revised: 08/29/2014
|
Accepted: 09/24/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (10)
|
Total Visits (22394)
|
Similar Articles (7)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):86-96.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.86
Abstract (1855)
|
Core Tip (1810)
|
Full Article (HTML) (8137)
|
Figures (1-3) (698)
|
Full Article (PDF)-2317K (912)
|
Peer-Review Report-102K (375)
|
Answering Reviewers-250K (431)
|
Received: 07/28/2014
|
Revised: 10/01/2014
|
Accepted: 10/29/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (17951)
|
Similar Articles (2)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):97-109.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.97
Abstract (1598)
|
Core Tip (1480)
|
Full Article (HTML) (6753)
|
Figures (1-1) (535)
|
Tables (1-4) (566)
|
Full Article (PDF)-1455K (803)
|
Peer-Review Report-129K (251)
|
Answering Reviewers-81K (265)
|
Received: 06/28/2014
|
Revised: 10/02/2014
|
Accepted: 11/10/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (15616)
|
Similar Articles (0)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Harnessing pharmacological knowledge for personalized medicine and pharmacotyping: Challenges and lessons learned
World J Pharmacol
3(4):110-119.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.110
Abstract (1610)
|
Core Tip (1398)
|
Full Article (HTML) (4440)
|
Figures (1-1) (530)
|
Tables (1-1) (493)
|
Full Article (PDF)-2534K (604)
|
Peer-Review Report-98K (310)
|
Answering Reviewers-19K (235)
|
Received: 06/12/2014
|
Revised: 07/03/2014
|
Accepted: 10/29/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (13979)
|
Similar Articles (7)
|
Timeline of Article Publication (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):120-139.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.120
Abstract (2016)
|
Core Tip (1622)
|
Full Article (HTML) (9390)
|
Figures (1-2) (639)
|
Tables (1-1) (461)
|
Full Article (PDF)-1376K (849)
|
Peer-Review Report-116K (526)
|
Answering Reviewers-78K (402)
|
Received: 06/29/2014
|
Revised: 09/01/2014
|
Accepted: 09/24/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (22786)
|
Similar Articles (74)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):140-152.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.140
Abstract (1986)
|
Core Tip (1825)
|
Full Article (HTML) (8644)
|
Figures (1-2) (521)
|
Tables (1-1) (498)
|
Full Article (PDF)-2415K (659)
|
Peer-Review Report-106K (460)
|
Answering Reviewers-72K (352)
|
Received: 06/27/2014
|
Revised: 10/02/2014
|
Accepted: 11/03/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (18)
|
Total Visits (18485)
|
Similar Articles (0)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(1)
|
Open
Minireviews
Pharmacological role of efflux transporters: Clinical implications for medication use during breastfeeding
World J Pharmacol
3(4):153-161.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.153
Abstract (1843)
|
Core Tip (1680)
|
Full Article (HTML) (6157)
|
Figures (1-1) (497)
|
Full Article (PDF)-1040K (654)
|
Peer-Review Report-104K (391)
|
Answering Reviewers-60K (323)
|
Received: 06/28/2014
|
Revised: 09/03/2014
|
Accepted: 09/24/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (15328)
|
Similar Articles (12)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):162-173.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.162
Abstract (1866)
|
Core Tip (1890)
|
Full Article (HTML) (8342)
|
Figures (1-2) (566)
|
Tables (1-1) (509)
|
Full Article (PDF)-4747K (904)
|
Peer-Review Report-116K (403)
|
Answering Reviewers-128K (407)
|
Received: 06/27/2014
|
Revised: 08/07/2014
|
Accepted: 10/29/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (21951)
|
Similar Articles (2)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):174-185.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.174
Abstract (1523)
|
Core Tip (1290)
|
Full Article (HTML) (5034)
|
Tables (1-1) (528)
|
Full Article (PDF)-1054K (503)
|
Peer-Review Report-106K (346)
|
Answering Reviewers-75K (256)
|
Received: 07/29/2014
|
Revised: 10/02/2014
|
Accepted: 10/27/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (12986)
|
Similar Articles (18)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):186-192.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.186
Abstract (1818)
|
Core Tip (1422)
|
Full Article (HTML) (8154)
|
Tables (1-2) (560)
|
Full Article (PDF)-872K (750)
|
Peer-Review Report-82K (376)
|
Answering Reviewers-100K (326)
|
Received: 05/16/2014
|
Revised: 07/04/2014
|
Accepted: 09/17/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (18303)
|
Similar Articles (31)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Therapeutics Advances
World J Pharmacol
3(4):193-198.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.193
Abstract (1605)
|
Core Tip (1310)
|
Full Article (HTML) (3020)
|
Figures (1-2) (453)
|
Tables (1-1) (474)
|
Full Article (PDF)-1053K (462)
|
Peer-Review Report-98K (381)
|
Answering Reviewers-31K (235)
|
Received: 06/24/2014
|
Revised: 09/22/2014
|
Accepted: 10/10/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (14346)
|
Similar Articles (790)
|
Timeline of Article Publication (2)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Evidence-Based Medicine
World J Pharmacol
3(4):199-208.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.199
Abstract (1808)
|
Core Tip (1637)
|
Full Article (HTML) (8045)
|
Tables (1-4) (633)
|
Full Article (PDF)-1067K (736)
|
Peer-Review Report-118K (358)
|
Answering Reviewers-113K (381)
|
Received: 07/28/2014
|
Revised: 09/08/2014
|
Accepted: 10/16/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (17748)
|
Similar Articles (84)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Systematic Reviews
Association of serum bilirubin and non-alcoholic fatty liver disease: A feasible therapeutic avenue?
World J Pharmacol
3(4):209-216.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.209
Abstract (1895)
|
Core Tip (1634)
|
Full Article (HTML) (10161)
|
Figures (1-1) (545)
|
Tables (1-2) (839)
|
Full Article (PDF)-1014K (618)
|
Peer-Review Report-80K (362)
|
Answering Reviewers-67K (272)
|
Received: 05/21/2014
|
Revised: 07/14/2014
|
Accepted: 10/27/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (20704)
|
Similar Articles (234)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
